Abstract CHI3L1 gene encodes for a glycoprotein (HC-gp39 or YKL40) secreted by synovial Wbroblasts, macrophages, neutrophil granulocytes and chondrocytes.
Introduction
Rheumatoid arthritis (RA) is a common systemic inXammatory disease aVecting »1% of the adult population worldwide [1] . The disease is characterized by inXammation of synovial tissue, progressive cartilage destruction and bone erosion of aVected joints [2] .
Despite signiWcant gains in knowledge of the immunopathology of RA, the exact etiology of the disease remains uncertain [1] . The genetic basis for RA is rather complex with a poorly understood cause. Several studies suggest roles of HLA-DRB1 [3] and PTPN22 [4] [5] [6] in RA pathogenesis. Three further RA risk loci have been identiWed recently, including the STAT4 gene [7] [8] [9] , loci in the 6q23 [10, 11] and TRAF1/C5 [12, 13] . RA is a major cause of disability and is even correlated with increased mortality in severe cases [14] . IdentiWcation of genetic risk factors of RA may help to understand basic mechanisms of autoimmunity and may be helpful in the development of targeted diagnostics and therapeutics.
Chitinase-3-like1 (CHI3L1) is a glycoprotein also known as human cartilage glycoprotein-39 (HC gp-39) or YKL-40. It has also been suggested to be a growth factor for connective tissue cells as well as a migration-promoting factor for endothelial cells [15] . It has been Wrst described as a major secretory product of rheumatoid synovial Wbroblasts by Nyirkos et al. [16] . Later it was demonstrated to be produced by articular chondrocytes and macrophages [17] . Its expression is under the control of NF-kB [18] . CHI3L1 mRNA was shown to be expressed in diseased human osteoarthritic cartilage and osteophyte, while it was not detected in healthy adult cartilage [19] . Peptides derived from HC gp-39 can bind to RA-associated DR4 (DRB1*0401) molecules and are recognized by peripheral blood T cells from patients with RA [20] . Furthermore, elevated levels of CHI3L1 are reported to be associated with inXammatory disorders, such as RA [21] [22] [23] .
Recently, functional variants of the promoter region of CHI3L1 (including rs4950928) have been shown to be associated with susceptibility to schizophrenia [24] . Also, a CHI3L1 gene polymorphism (rs10399931) has been reported to contribute to inter-individual variations of the CHI3L1 levels in sarcoidosis [25] .
Given the known elevated levels of CHI3L1 in various inXammatory diseases reported by numerous groups [21] [22] [23] , in this study we made an attempt to identify a possible disease association of functional single nucleotide polymorphisms (SNPs) of CHI3L1 in a Hungarian cohort of patients with RA and healthy controls.
Materials and methods

Subjects
We examined 182 patients suVering from RA (156 women, 26 men, mean age 61.98 § 10.51, range 32-85), treated in the Department of Rheumatology, County Hospital Kecskemét, Hungary.
Control subjects (94 men and 100 women; aged 36.8 § 10.5 years) with no known history of inXammatory arthritis were randomly selected from healthy blood donors (n = 192) of the same ethnicity and from the same geographical region as the patients. All study subjects belonged to the Hungarian (Caucasian) population, and all patients with RA had the typical symptoms and diagnosis of RA. All patients with RA met the American College of Rheumatology criteria for rheumatoid arthritis [26] .
During the entire investigation period, the guidelines and regulations approved by the local Ethical Committee and the Helsinki Declaration in 1975 were followed; the patients gave their informed consent for use of their anonymized DNA samples for research purposes.
Genotyping
Genomic DNA was extracted from EDTA anticoagulated whole blood-derived buVy coats, after sedimentation at room temperature. A commercial kit QIAamp ® DNA blood mini kit (QIAGEN Inc, Chatsworth, CA, USA) was used following the instructions of the manufacturer.
Biallelic SNP genotyping was performed with TaqMan allelic discrimination assays (Applied Biosystems) according to the recommendations of the manufacturer. PCR was performed using an ABI 7000 thermocycler, and Xuorescent signals were analyzed using an ABI 7000 sequence detector single point measurement and SDS v2.3 software (Applied Biosystems).
The following assays were used for allelic discrimination in the study:
CHI3L1-1 (rs10399931) and CHI3L1-2 (rs4950928). PCR was performed with components including 12.5 l Mastermix, 9.2 l distilled water, 2 l DNA (10 ng/ l), 1.3 l of primers and probes. The total reaction mixture was thus 25 l /well. The following cycle was repeated 45 times: 50°C-2 min, 95°C-10 min, 95°C-15 s, 60°C-1 min.
Clinical and laboratory parameters
Gender, age of onset of the disease, levels of C-reactive protein (CRP), seropositivities for rheumatoid factor (RF) and anti-CCP antibodies, and the current disease activity scores (DAS28) of the patients were documented for all patients with RA. Controls did not suVer from any known joint diseases.
Statistical analysis
Genotypes were determined for all samples, and each SNP was assessed for deviation from Hardy-Weinberg equilibrium. Both allelic and genotypic association tests and Cochran-Armitage tests were performed using an online HWE calculator (http://ihg2.helmholtz-muenchen.de/cgibin/hw/hwa1.pl) [27] . Associations with susceptibility to RA were tested by calculating odds ration (OR) and 95% conWdence interval (CI).
Results
We tested the possible association of two functional SNPs of the CHI3L1 gene with RA in a Hungarian cohort of patients by using allelic discrimination system. The baseline characteristics of the patients are summarized in Table 1 .
Genotype frequencies were determined for both tested SNPs. Allele and genotype frequencies of the SNPs were calculated and are shown in Table 2 . No deviation from the Hardy-Weinberg equilibrium (HWE) was observed either in patients with RA or in controls. A comparison of allele and genotype frequencies of the polymorphism under study revealed no statistically signiWcant diVerences between patients with RA and healthy controls (Table 3) .
After adjusting for age and gender using logistic regression, there was no signiWcant association between the SNPs and RA (we tested also their interaction; data not shown).
Discussion
RA is a systemic autoimmune disease with complex genetic background, and dissecting its genetic components may shed light on important mechanism underlying the development of autoimmunity in susceptible individuals.
Several studies examined the role of CHI3L1 and reported to be associated with inXammatory disorders, such as RA [21] [22] [23] . Recently, the promoter SNP of the CHI3L1 gene (rs4950928) was found to be associated with elevated serum CHI3L1 levels as well in asthma, bronchial hyperresponsiveness and measures of pulmonary functions [29] .
The same polymorphism was also demonstrated to be associated with schizophrenia [27] . The elevated levels and suggested role of CHI3L1 in the regulation of cytokine signaling as well as its protective role in inXammatory environments [28] were compelling to hypothesize that functional polymorphisms of the CHI3L1gene might be associated with RA.
Surprisingly, there were no signiWcant diVerences in the distributions of alleles and genotypes between the patients with RA and controls. Haplotype analysis of these two polymorphisms did not show diVerences between the two groups either.
We also carried out power analysis in order to reWne our conclusions. Assuming a dominant model, the sample size in the study (377), and a signiWcance level 0.05, we investigated the power for the estimated allele frequency range (22-29.5%) and the estimated OR range (<4). We found that the power diminished below OR = 2, thus, based on our data, we cannot exclude associations with RA below this level.
Our present data argue that the reported elevated CHI3L1 levels in RA might be consequences rather than causative components of the inXammatory processes in RA. However, further SNPs of the CHI3L1 gene need to be tested in order to entirely rule out the association of the gene with RA susceptibility.
